|4Sep 18, 8:00 AM ET

Foster Robert T 4

4 · Hepion Pharmaceuticals, Inc. · Filed Sep 18, 2023

Insider Transaction Report

Form 4
Period: 2023-09-15
Foster Robert T
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2023-09-15$5.40/sh+1,600$8,64048,870 total

Documents

1 file
  • 4
    tm2326273-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT